概括
斯芬戈氨基激酶1 (SK1) 活性是由形状变化调节的. 像PF-543这样的抑制剂稳定了不活性的SK1状态,为癌症和其他疾病提供了新的治疗策略.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 化学生物学 化学生物学
背景情况:
- 斯芬戈辛基因酶1 (SK1) 产生斯芬戈辛-1-酸盐,这是一个参与癌症进展的脂质介质.
- 了解SK1的结构和动态对于开发有针对性的疗法至关重要.
- SK1的调节和抑制机制尚未完全阐明.
研究的目的:
- 研究SK1调节和抑制的结构和动态基础.
- 揭示控制基质进入,催化和抑制剂结合的机制.
- 为设计新型SK1抑制剂提供结构框架.
主要方法:
- 综合光谱和计算方法.
- 对形状转变和调节循环重新安排的分析.
- 催化中间体和抑制剂结合状态的表征.
主要成果:
- 酸化Ser225诱导膜参与和活性的结构变化.
- 确定了一种具有动态脂质结合环 (LBL-1) 的新型催化中间体.
- 抑制剂PF-543通过限制LBL-1动态,将SK1锁定在一个不活跃的形状中.
- SK1形成由连接体或膜相互作用调节的功能上不同的二元体.
结论:
- SK1 调节涉及动态形状转换和多层机制.
- 定义了一种针对SK1结构灵活性的新型抑制机制.
- 这些发现为开发下一代SK1向治疗提供了结构性基础.
相关概念视频
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
Amplifying Signals via Enzymatic Cascade
8.2K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.2K
Allosteric Regulation
57.3K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
57.3K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Protein Kinases and Phosphatases
13.0K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.0K
Feedback Inhibition
53.5K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
53.5K


